A total of 118,340 SAS-B approvals were issued by the Therapeutic Goods Administration (TGA) in 2022, down from 122,011 in 2021 – the first time the figure has fallen year-on-year.
However, following TGA reforms introduced in November 2021, prescribers now require fewer approvals, even though they may be prescribing more medicine.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.